Skip to main content
All lobbying filings

REVVITY, INC.

Lobbying for REVVITY, INC.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 expenses · posted Jan 9, 2026

Official filing document

 Bills named in this filing 2
  • HR 4709
    Newborn Screening Saves Lives Reauthorization Act of 2025
  • HR 2810
    Family Cord Blood Banking Act
 Lobbying activity 1
Health Issues

Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem